US 9452175
Pregnancy hormone combination for treatment of autoimmune diseases
granted A61KA61K31/56A61K31/565
Quick answer
US patent 9452175 (Pregnancy hormone combination for treatment of autoimmune diseases) held by The Regents of the University of California expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/56, A61K31/565, A61K31/57, A61K31/785